Home / Inspections / 1250648

FDA Inspection 1250648 — University of Texas MD Anderson Cancer Center

University of Texas MD Anderson Cancer Center — FEI 3010547404

The FDA completed an inspection of University of Texas MD Anderson Cancer Center on September 16, 2024 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 16, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)

Facility

Other inspections at this facility

  • 1305506 (NAI Fri Feb 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1165594 (VAI Thu Mar 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1115530 (NAI Thu Dec 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources